Warren Eric

Chief Commercial Officer

1 company

Good

Trades Analyzed

12M Win Rate

38.5%

Avg 3M Return

+7.7%

Avg 12M Return

-1.6%

Warren Eric is a Chief Commercial Officer at Esperion Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $1.2M based on current market prices.

Holdings by Company

ESPRApr 17, 2025

Current Shares370.2K

Value$1.17M

Net Activity-19,188

Bought: 1.0KSold: 20.2K

Showing 10 filings (page 2)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Jun 18, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	2,540	$2.86	$7,254.24	-1.5%	-35.3%	-59.6%
May 17, 2024	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	192	$2.48	$476.74	-0.1%	-16.5%	-66.0%
Sep 20, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	742	$1.25	$923.79	-1.1%	+103.5%	+52.2%
Aug 18, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	243	$1.41	$343.60	-0.4%	-23.4%	+35.2%
Jul 19, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	106	$1.59	$168.01	-0.2%	-38.8%	+59.1%
Jun 21, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	603	$1.48	$894.25	-0.9%	-12.4%	+61.8%
May 17, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	219	$1.62	$355.66	-0.3%	-6.8%	+47.2%
Apr 19, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	115	$1.28	$146.97	-0.2%	+19.8%	+42.7%
Mar 17, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	526	$1.78	$937.49	-0.7%	-11.6%	+33.5%
Mar 7, 2023	ESPR Esperion Therapeutics, Inc.	Chief Commercial Officer	Sell	5,090	$5.06	$25,729.95	-9.5%	-72.5%	-49.8%